These observations were consistent with primary tumour data from TCGA, since CASP8 mRNA levels in tumours with mutant CASP8 did not differ from those with wild type CASP8 at a given copy number, whereas there was a trend to lower FAT1 mRNA levels in tumours bearing FAT1 mutations (Fig. 2E). This evidence concerns the gene CASP8 and neoplasm.